Federal regulators lift pause on Johnson & Johnson COVID-19 vaccine

Published



Federal regulators have lifted the recommended pause on administering the Johnson & Johnson vaccine, giving states the license to use the shot that has proven to be a lifeline for remote communities unable to properly transport and store it.

The independent panel of vaccine experts at the Centers for Disease Control and Prevention on Friday recommended lifting the pause on the Johnson & Johnson vaccine, with many committee members saying that the benefits outweighed the risks. The panelists also recommended that the Food and Drug Administration consider adding a warning label for women under 50.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.